New Hampshire loses more than 400 residents to drug overdose deaths every year, according to the NH Department of Health and Human Services, and the majority now involve fentanyl. If you are trying to figure out where to start with addiction treatment in New Hampshire, the volume of options and the urgency of the situation can make the decision feel impossible. This guide cuts through that noise, giving you a clear framework for choosing the right level of care, evaluating facilities, understanding your insurance, and taking the one action that actually moves things forward.
The scale of addiction in new hampshire
New Hampshire consistently ranks among the states with the highest per-capita overdose death rates in the country. According to the CDC’s most recent state-level data, New Hampshire recorded 40.4 overdose deaths per 100,000 residents, placing it in the top tier nationally. The NH DHHS reported 478 drug overdose deaths in 2023 alone, with fentanyl or fentanyl analogs detected in more than 90 percent of those cases.
What these numbers mean for families making decisions right now is simple: treatment demand is high, beds fill quickly, and waiting for a perfect plan costs time that most people in active addiction do not have. A 2021 study published in JAMA Psychiatry, analyzing data from 28,000 individuals with opioid use disorder, found that the mortality risk during the period immediately following a treatment attempt that does not result in enrollment is significantly elevated compared to the risk during active treatment. The window to act matters.
The takeaway is not that you should panic. It is that choosing quickly and getting someone into an appropriate level of care beats researching endlessly and making no move at all. Understanding what the continuum of care looks like is what makes a fast decision a good decision.
How addiction treatment works: the core continuum
The American Society of Addiction Medicine, known as ASAM, publishes criteria that define the appropriate level of care based on six dimensions: intoxication and withdrawal risk, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and the living environment. Facilities that use these criteria match patients to care based on clinical need, not bed availability or financial incentive.
The levels run from medically managed intensive inpatient care (the highest, typically called detox) through residential treatment, partial hospitalization programs (PHP), intensive outpatient programs (IOP), and standard outpatient. Each step down represents a lower level of structure and medical oversight. Understanding this progression helps you ask the right questions when you call a facility: not “do you have space?” but “what level of care are you recommending and why?”
Medical detox: why it comes first
Medical detox is the process of clearing substances from the body under medical supervision, with clinical staff managing withdrawal symptoms to keep the process safe. For alcohol, opioids, and benzodiazepines, withdrawal is not just uncomfortable. It can be life-threatening.
The New England Journal of Medicine has published extensively on alcohol withdrawal syndrome, noting that severe withdrawal can progress to generalized tonic-clonic seizures and delirium tremens, with untreated delirium tremens carrying a mortality rate of up to 15 percent. Opioid withdrawal, while rarely fatal on its own, carries serious risk through dehydration, cardiac stress, and the near-certain relapse that follows unmanaged symptoms, often at doses that cause overdose because tolerance has dropped.
Medical detox typically lasts three to seven days depending on the substance and the person’s history. The goal is stabilization, not treatment of the underlying addiction. That is what residential care addresses. If the person you are concerned about has been drinking heavily every day for weeks or months, or has been using opioids regularly, the first call goes to a detox facility.
Residential treatment: what happens inside
Residential treatment means living at the facility for the duration of the program, typically 30, 60, or 90 days, with a structured daily schedule built around evidence-based therapies. A typical day includes individual therapy sessions using approaches like cognitive behavioral therapy (CBT) or dialectical behavior therapy (DBT), group therapy, psychoeducation on addiction and relapse prevention, and meals in a communal setting. Medication-assisted treatment, or MAT, is administered and monitored by clinical staff in programs equipped to provide it.
Research published in the Journal of Substance Abuse Treatment found that longer residential stays, specifically those exceeding 90 days, were associated with significantly better outcomes at one-year follow-up across alcohol, opioid, and stimulant use disorders. The mechanism is straightforward: more time in a structured, substance-free environment allows neural recovery and skills development that shorter stays do not.
When you are evaluating residential programs, ask for their six-month sobriety outcome data. Reputable facilities track it. If a program cannot tell you what percentage of their graduates are still in recovery at six months, that is a gap worth noting.
Outpatient options: when they work and when they don’t
Partial hospitalization programs run four to six hours per day, five days per week. Intensive outpatient programs typically meet nine to 12 hours per week across three days. Standard outpatient might be one to two sessions weekly. All three keep the person living at home while receiving structured treatment.
A 2020 analysis published in Drug and Alcohol Dependence found that outpatient treatment produces comparable outcomes to residential treatment, but only for individuals with stable housing, strong social support networks, low medical acuity, and no recent relapse history. For people who lack those conditions, outpatient is not a lower-cost shortcut. It is a clinically inappropriate level of care. ASAM offers a free level-of-care self-assessment tool online that maps an individual’s situation to the recommended care setting. Use it before calling outpatient programs.
Substance-specific considerations in new hampshire
New Hampshire’s substance use landscape has shifted sharply. Fentanyl now drives the overwhelming majority of overdose deaths, but alcohol use disorder remains the most prevalent substance use disorder in the state by volume. Methamphetamine seizures by NH law enforcement have increased every year since 2020, according to NH DHHS Bureau of Drug and Alcohol Services data. Each substance creates different clinical needs, and those needs should shape which type of facility you choose.
Opioid and fentanyl addiction
The NH DHHS reported that fentanyl was detected in 92 percent of drug overdose deaths in 2023. The potency of illicit fentanyl means that tolerance develops rapidly and that the margin between a using dose and a lethal dose is extremely narrow, especially after any period of abstinence.
For opioid use disorder, medications for opioid use disorder (MOUD), which include buprenorphine, methadone, and naltrexone, are not optional add-ons. A 2019 study in the New England Journal of Medicine found that buprenorphine reduced opioid use disorder-related mortality by 38 percent compared to behavioral treatment alone. Choosing a facility that does not offer MAT for opioid dependence is choosing a program with substantially worse outcomes. When you call a facility, ask directly: “Do you prescribe and continue buprenorphine or methadone for opioid use disorder during residential care?” A yes or no answer tells you what you need to know.
Alcohol use disorder
Alcohol withdrawal carries the highest physiological risk of any commonly used substance. The risk of seizure typically begins six to 24 hours after the last drink and can progress to delirium tremens between 24 and 72 hours. A study published in Alcohol and Alcoholism found that individuals who had sustained daily drinking for more than three weeks faced a meaningfully higher risk of severe withdrawal compared to episodic heavy drinkers.
Medical detox for alcohol requires benzodiazepine tapering protocols managed by licensed clinical staff, along with monitoring for cardiac changes and hydration status. This is categorically different from opioid detox management. The practical rule: if you or someone close to you has been drinking every day for more than a few weeks, attempting withdrawal at home is not appropriate. The first step is medically supervised detox, full stop.
Co-occurring mental health conditions
SAMHSA’s 2022 National Survey on Drug Use and Health found that 21.5 million adults in the United States had a co-occurring substance use disorder and mental health condition in the previous year. In New Hampshire, the NH DHHS estimates that more than half of individuals entering substance use disorder treatment have a diagnosable co-occurring mental health condition.
Programs that treat addiction in isolation, without evaluating and addressing underlying depression, anxiety, PTSD, or other conditions, produce worse outcomes because the underlying driver of use remains untreated. Ask any facility you are considering whether psychiatric evaluation is included in the intake process and whether ongoing mental health treatment is integrated into the residential program, not referred out to a separate provider after discharge.
How to evaluate a treatment facility in new hampshire
Quality in addiction treatment is not self-reported. It is verified through accreditation status, licensing, staff credentials, and a transparent conversation about outcomes. Two accreditation bodies set the standard for behavioral health programs: The Joint Commission and CARF International. Both conduct independent reviews of clinical protocols, staff qualifications, patient rights practices, and physical safety. A 2018 study in Psychiatric Services found that Joint Commission-accredited behavioral health facilities had significantly lower rates of adverse events and patient complaints compared to non-accredited facilities.
Licensing in New Hampshire is managed by the Bureau of Drug and Alcohol Services within the NH DHHS. All substance use disorder treatment facilities operating in the state are required to hold a current license from BDAS. You can verify a facility’s licensing status by calling the NH DHHS directly. Staff credentials to look for include: Licensed Clinical Mental Health Counselor (LCMHC), Master Licensed Alcohol and Drug Counselor (MLADC), Medical Doctor or Doctor of Osteopathy (MD/DO), and Registered Nurse (RN). A residential facility without licensed clinical staff on site around the clock is not a residential facility in any meaningful clinical sense.
For those specifically exploring options in the northern part of the state, resources focused on care in Bethlehem and surrounding communities can help you understand what local residential treatment looks like in practice.
Questions to ask before you commit
Before enrolling yourself or a family member in any residential program in New Hampshire, ask these five questions directly:
Do you offer medication-assisted treatment, specifically buprenorphine or methadone, for opioid use disorder during residential care? This filters immediately for evidence-based opioid treatment.
What are your 90-day sobriety outcomes for graduates? Reputable programs measure and share this. Evasion or vague answers are informative.
What does a typical daily schedule look like, including how many hours of individual therapy per week? Individual therapy time is one of the clearest proxies for clinical intensity.
Is family involvement part of the program, and if so, how? Research consistently links family engagement to better long-term outcomes. Programs that exclude family entirely during treatment are worth scrutinizing.
What is the discharge plan if I need a higher level of care mid-program, or a lower one? Clinical needs change. A good program has a clear answer because this happens regularly.
Red flags to watch for
The FTC and SAMHSA have both published guidance on predatory rehabilitation practices, which increased significantly during the last decade as treatment demand surged. The warning signs are specific.
Any facility that guarantees recovery should be disqualified immediately. Recovery is not a guaranteed outcome of any program, and facilities that claim otherwise are making a promise they cannot deliver. Facilities that require you to discontinue MAT on admission are practicing against clinical evidence and SAMHSA guidelines. Requiring that someone stop buprenorphine to enter treatment is not a clinical standard; it is a policy choice that increases risk. Facilities that cannot produce a current NH DHHS license or Joint Commission and CARF accreditation documentation on request are not verifiable. Facilities that present long-term contracts and require full payment upfront before clinical assessment has occurred should be avoided.
If a facility refuses to answer any of the questions from the previous section, end the call and move to the next option on your list.
Understanding your insurance coverage in new hampshire
The Mental Health Parity and Addiction Equity Act (MHPAEA), enacted in 2008 and strengthened by subsequent regulations, requires that health insurers who provide mental health and substance use disorder benefits do so at parity with medical and surgical benefits. In practical terms, this means that if your insurer covers medical hospitalization, it cannot impose stricter limits on residential addiction treatment without clinical justification.
A 2023 report from the American Journal of Psychiatry found that parity violations in behavioral health are common but successfully challenged through appeals at a meaningful rate. Knowing that parity law exists means you have standing to push back when an insurer denies residential care for reasons that would not apply to a medical admission. Facilities in New Hampshire that accept commercial insurance, including Aetna, Anthem, Cigna, Harvard Pilgrim, and Tufts, routinely assist with parity-based appeals.
If you are evaluating programs across the region and want to understand how to choose the right facility for your specific situation, benefits verification is the first practical step before any other commitment.
How to use medicaid for addiction treatment in NH
New Hampshire Medicaid manages substance use disorder benefits through three managed care organizations: WellSense Health Plan (formerly Boston Medical Center HealthNet Plan), AmeriHealth Caritas New Hampshire, and Granite State Health Plan. All three are required by the state to cover medically necessary detox and residential treatment, though prior authorization requirements and network restrictions vary by plan.
A 2022 analysis by the Kaiser Family Foundation found that Medicaid is the single largest payer for substance use disorder treatment nationally, covering roughly 40 percent of all treatment episodes. In New Hampshire, Medicaid expansion under the ACA significantly increased access for working-age adults with low income.
The action step here is specific: call the member services number on the back of your Medicaid card and ask for “substance use disorder benefits.” Using that exact phrase routes you to the right department. Ask what prior authorization is required for residential detox and residential treatment, what your in-network residential facilities are, and whether out-of-network coverage is available if no in-network residential beds are accessible in your region.
Using commercial insurance or tricare
Commercial insurance plans from Aetna, Anthem, Cigna, Harvard Pilgrim, and Tufts all cover residential substance use disorder treatment, but coverage parameters, specifically in-network versus out-of-network reimbursement rates, deductibles, and co-insurance percentages, vary significantly. Getting a pre-authorization for residential treatment before admission is standard practice and reduces the risk of a surprise denial after discharge.
TRICARE covers behavioral health treatment, including residential substance use disorder treatment, for eligible beneficiaries. TRICARE Prime and TRICARE Select both cover inpatient substance use disorder treatment, with prior authorization required for most residential stays. TRICARE’s behavioral health line (1-800-700-8646) handles pre-authorization requests and can confirm in-network facility status.
The simplest move for anyone with commercial insurance or TRICARE is to request a benefits verification call with the admissions team of the facility you are considering before committing to anything. Legitimate facilities do this routinely. They contact your insurer, confirm your coverage, estimate your out-of-pocket costs, and walk you through what is and is not covered before you sign anything.
Finding treatment resources across new hampshire
New Hampshire is geographically large and rural in significant portions, particularly in Grafton County and the White Mountains region. For residents of towns like Woodstock, Lincoln, or Franconia, the nearest outpatient provider may be 45 minutes away. This access gap is documented in research: a 2020 study in Health Affairs found that rural residents with substance use disorders were 40 percent less likely to receive any form of specialty addiction treatment compared to urban residents, primarily due to transportation barriers and provider scarcity.
Residential treatment addresses the access problem directly. When treatment is residential, proximity to local outpatient providers becomes irrelevant for the duration of the program. The state’s primary phone resource for immediate connection to care is the NH Rapid Response Access Point, reachable at 1-833-710-6477. The line is staffed 24 hours a day, seven days a week, and staff can direct you to appropriate care within the hour. SAMHSA’s national treatment locator at findtreatment.gov allows you to search by zip code and filter by insurance type, substance, and level of care.
Northern new hampshire and grafton county
Grafton County and the White Mountains region present a particular set of access challenges: fewer licensed outpatient providers per capita, longer travel distances, limited public transportation, and, for many residents, social networks that are closely tied to substance use. These factors combine to make outpatient treatment less viable as a starting point for many individuals in this area.
Residential treatment in northern New Hampshire addresses both the access barrier and the environmental trigger problem simultaneously. Leaving the immediate environment, even temporarily, removes the proximity to people, places, and situations associated with use, which is a documented factor in early recovery. Research published in the Journal of Studies on Alcohol and Drugs found that environmental change during early recovery was associated with lower rates of early relapse compared to remaining in the home environment during treatment.
For those specifically in Grafton County, understanding what residential options exist in the region can help narrow the search quickly. For context on the broader northern tier, a focused look at treatment programs in the northern part of the state provides additional geographic detail on what is available and how programs in this setting operate.
What to expect after residential treatment
Residential treatment is the beginning of recovery, not the end of it. NIDA’s research on relapse rates makes this clear: without continuing care after residential treatment, relapse rates within the first year approach 40 to 60 percent. With structured aftercare, those rates drop meaningfully. The difference is not willpower. It is whether the structure and support of treatment are replaced by something, or by nothing.
Aftercare typically follows a step-down model: from residential to a partial hospitalization program, then to intensive outpatient, then to standard outpatient, with ongoing peer recovery support and, where appropriate, continued MAT. Sober living environments provide a substance-free living situation during the early outpatient phase for individuals who do not have a stable home environment to return to. SMART Recovery and 12-step programs like Alcoholics Anonymous and Narcotics Anonymous provide ongoing community connection that extends the social support network beyond the clinical setting.
A 2017 Hazelden Betty Ford study found that individuals who participated in structured continuing care for at least 12 months post-residential had significantly higher rates of sustained sobriety at the two-year mark compared to those who transitioned directly to unstructured community support. The mechanism is sustained accountability and skill reinforcement over time.
Before discharge from any residential program, confirm that a step-down plan with specific appointments is already scheduled. Not a referral list with phone numbers to call. Actual scheduled appointments with providers who are expecting the person. That distinction is what separates a discharge plan that works from one that exists on paper.
What to do this week
Everything in this guide points toward one action that is available to you right now: call the NH Rapid Response Access Point at 1-833-710-6477. The line is staffed around the clock, the staff are trained in level-of-care assessment, and a single call can result in a placement recommendation and direct connection to a facility within hours. If you have already identified a facility you want to learn more about, call their admissions line today and ask for a benefits verification. That call costs nothing and answers the insurance questions that are often the biggest perceived barrier to moving forward. More research is not the bottleneck. The call is.
Frequently asked questions
How long does addiction treatment in new hampshire typically take?
The duration depends on the level of care and the individual’s clinical needs. Medical detox typically lasts three to seven days. Residential treatment programs run 30, 60, or 90 days, with research supporting longer stays for better outcomes. After residential care, step-down programs like PHP and IOP extend structured support for several additional months. A complete continuum from detox through outpatient, with ongoing peer support, typically spans six to 12 months at minimum.
Does new hampshire medicaid cover residential addiction treatment?
Yes. All three New Hampshire Medicaid managed care organizations, WellSense, AmeriHealth Caritas, and Granite State Health Plan, are required by the state to cover medically necessary residential detox and residential treatment. Prior authorization is required and the process varies by plan. Call the member services number on your Medicaid card and ask specifically for substance use disorder benefits to be connected to the right department.
Can I travel from another part of new hampshire for residential treatment?
Yes, and for many people it is the right clinical choice. Residential programs in New Hampshire accept clients from across the state. Traveling for treatment removes you from the environment, relationships, and routines associated with substance use, which research links to better early recovery outcomes. Facilities handle intake remotely, and most will coordinate transportation information as part of the admissions process.
What is the difference between detox and residential treatment?
Detox is the medically supervised process of clearing substances from the body and managing withdrawal safely. It addresses the acute physical phase, typically over three to seven days, but does not treat the underlying addiction. Residential treatment begins after stabilization and focuses on the psychological, behavioral, and social dimensions of addiction through structured therapy, skills development, and peer community. Both are often necessary for individuals with physical dependence.
What should I do if my insurance denies coverage for residential treatment?
Request a detailed explanation of the denial in writing, then file a formal appeal. Under the Mental Health Parity and Addiction Equity Act, insurers cannot apply more restrictive criteria to residential addiction treatment than they apply to comparable medical inpatient care. If the internal appeal is denied, you have the right to an independent external review. Many facilities have staff whose role is to assist with insurance appeals and can guide you through the process.
Is medication-assisted treatment available in new hampshire residential programs?
Not universally, which is why asking directly matters. SAMHSA and ASAM guidelines both support the use of buprenorphine, methadone, and naltrexone in residential settings for opioid use disorder. Programs that prohibit MAT on admission are operating against clinical evidence and federal guidelines. When evaluating any facility, ask explicitly whether they prescribe and continue MAT during residential care. For opioid use disorder specifically, the answer to that question is one of the most important criteria in your decision.